These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30255533)

  • 21. [Community pharmacists, students in pharmacy, and requests of codeine-based medicines: Observational study].
    Baumevieille M; Rambaud A; Perri-Plande J; Daveluy A
    Therapie; 2020; 75(6):569-577. PubMed ID: 31937467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Purple drank: A dangerous cocktail].
    Garcin L; Le Roch M; Agbessi CA; Lobut JB; Lecoeur A; Benoist G
    Arch Pediatr; 2016 Nov; 23(11):1165-1168. PubMed ID: 27670723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing inappropriate use of non-prescription combination analgesics containing codeine: A modified Delphi study.
    Gibbins AK; Wood PJ; Spark MJ
    Res Social Adm Pharm; 2017; 13(2):369-377. PubMed ID: 27084506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of psychoactive prescription drugs among DUI suspects.
    Karjalainen K; Haukka J; Lintonen T; Joukamaa M; Lillsunde P
    Drug Alcohol Depend; 2015 Oct; 155():215-21. PubMed ID: 26282109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
    Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J;
    Therapie; 2020; 75(4):343-354. PubMed ID: 32660776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
    Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J
    Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of overlapping prescriptions of psychotropic drugs by community pharmacists.
    Shimane T; Matsumoto T; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Oct; 47(5):202-10. PubMed ID: 23393998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK.
    Layton D; Sinclair HK; Bond CM; Hannaford PC; Shakir SA
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):503-13. PubMed ID: 12426936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Codeine consumption from over-the-counter anti-cough syrup in Taiwan: A useful indicator for opioid abuse.
    Lo MY; Ong MW; Lin JG; Sun WZ
    Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):135-8. PubMed ID: 26646544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription drug diversion among substance-impaired pharmacists.
    Merlo LJ; Cummings SM; Cottler LB
    Am J Addict; 2014; 23(2):123-8. PubMed ID: 25187048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription and over-the-counter drug treatment admissions to the California public treatment system.
    Gonzales R; Brecht ML; Mooney L; Rawson RA
    J Subst Abuse Treat; 2011 Apr; 40(3):224-9. PubMed ID: 21193282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel psychoactive substances: risks and harms.
    O'Neill C
    Community Pract; 2014 Aug; 87(8):45-7. PubMed ID: 25226709
    [No Abstract]   [Full Text] [Related]  

  • 33. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)].
    Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP
    Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misuse of OTC drugs in Poland.
    Zaprutko T; Koligat D; Michalak M; Wieczorek M; Józiak M; Ratajczak M; Szydłowska K; Miazek J; Kus K; Nowakowska E
    Health Policy; 2016 Aug; 120(8):875-81. PubMed ID: 27344198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ophthalmic drug abuse: An observational study from community pharmacies.
    Al-Khalaileh W; Abu-Farha R; Wazaify M; Van Hout MC
    Res Social Adm Pharm; 2019 Aug; 15(8):943-948. PubMed ID: 30737195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychoactive substances use in Réunion Island and Mayotte, French departments in Indian Ocean].
    Daveluy A; Haramburu F
    Therapie; 2018 Oct; 73(5):419-427. PubMed ID: 29773359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017.
    Kurtz SP; Buttram ME; Margolin ZR; Wogenstahl K
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):700-706. PubMed ID: 30909323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues.
    Sinclair HK; Bond CM; Hannaford PC
    Drug Saf; 2001; 24(12):929-38. PubMed ID: 11735649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Best Practices and Innovations for Managing Codeine Misuse and Dependence.
    Norman IJ; Bergin M; Parry CD; Van Hout MC
    J Pharm Pharm Sci; 2016; 19(3):367-381. PubMed ID: 27806253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.